ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 745–756 of 2020 project topics
Personalized Probiotic Formulation Engine Using Genetic Profiling
Commercial SaaS platform that analyzes patient genetic variants to recommend strain-specific probiotic formulations tailored to individual microbiome composition. Generates recurring revenue through subscription-based recommendations, integration partnerships with supplement manufacturers, and direct-to-consumer diagnostic kits.
Microbiome Genetics and Host Interactions Click to view more details →
Pharmacogenomic Microbiome Drug Interaction Prediction Software
Clinical decision support tool that predicts how patient genetic profiles and microbiome composition affect medication metabolism and efficacy. Delivers value through licensing to pharmaceutical companies, healthcare systems, and enables precision medicine pricing models for personalized drug dosing.
Microbiome Genetics and Host Interactions Click to view more details →
Microbial Metabolite Production Optimization Platform for Therapeutics
Industrial biotech software that uses host genetic data and microbiome genetics to design engineered bacteria producing therapeutic metabolites for precision medicine applications. Monetizes through licensing agreements with biotech firms, contract manufacturing partnerships, and royalties on commercialized microbial therapeutics.
Microbiome Genetics and Host Interactions Click to view more details →
Dietary Genomics Recommendation Engine for Microbiome Health
Consumer wellness platform integrating host genetics and microbiome sequencing to generate personalized nutrition protocols that optimize microbial community structure. Captures revenue through genetic testing fees, monthly subscription tiers, food partnership integrations, and licensed content distribution.
Microbiome Genetics and Host Interactions Click to view more details →
Disease Risk Stratification Tool Using Microbiome-Host Genetic Signatures
Diagnostic analytics platform that combines human genetic polymorphisms with microbiome genetic markers to predict susceptibility to gastrointestinal and metabolic diseases. Generates B2B revenue through clinical laboratory licensing, health insurance integration, and preventive care program partnerships.
Microbiome Genetics and Host Interactions Click to view more details →
Microbiome Engineering Service for Genetic Disease Therapeutic Development
Contract research and manufacturing service that engineers microbiota compositions optimized for host genetic backgrounds to treat genetic disorders. Creates value through service fees for pharmaceutical development projects, milestone payments, and equity participation in licensed microbiome therapeutics.
Microbiome Genetics and Host Interactions Click to view more details →
Antipsychotic Response CYP2D6 Genotyping
Developing CYP2D6 genotyping panels for predicting antipsychotic drug metabolism and optimizing risperidone, aripiprazole, and haloperidol dosing.
Pharmacogenomics of Psychiatric Medications Click to view more details →
Antidepressant Response Pharmacogenomics
Identifying CYP2C19 and SLC6A4 variants associated with SSRI response and side effects for improving antidepressant medication selection.
Pharmacogenomics of Psychiatric Medications Click to view more details →
Lithium Response Genetics in Bipolar Disorder
Discovering genetic variants associated with lithium treatment response in bipolar disorder for identifying patients likely to benefit from lithium therapy.
Pharmacogenomics of Psychiatric Medications Click to view more details →
Clozapine Agranulocytosis HLA Risk Testing
Implementing HLA-B*11:01 pre-treatment testing for identifying patients at elevated risk for clozapine-induced agranulocytosis before treatment initiation.
Pharmacogenomics of Psychiatric Medications Click to view more details →
SSRI Metabolizer Status SaaS Platform for Dosing
A cloud-based clinical decision support tool that analyzes CYP2C19 and CYP2D6 variants to predict SSRI metabolism rates and recommend personalized dosing protocols. This platform reduces trial-and-error prescribing, decreases adverse events, and enables subscription-based revenue through healthcare providers and psychiatric clinics.
Pharmacogenomics of Psychiatric Medications Click to view more details →
Tricyclic Antidepressant Pharmacogenomic Testing Service
A laboratory testing service that genotypes CYP1A2, CYP2D6, and CYP3A4 variants to predict tricyclic drug metabolism and optimize dosing for treatment-resistant depression. This service generates revenue through per-test billing, payer reimbursement, and partnerships with psychiatric hospitals and residential treatment facilities.
Pharmacogenomics of Psychiatric Medications Click to view more details →